GrowHub LtdTGHL

Singapore’s GrowHub Ltd filed its 20-F for the year ended 31 December 2025 with a balance sheet that reads like a cautionary tale: $1.0M in total assets against $3.3M in liabilities, leaving stockholders’ equity at a neat $-2.3M. Revenue for the year was a mere $64,574, while the company posted a net loss attributable to parent of $-13.4M, or $-0.59 per diluted share on 22.8M shares outstanding. Operating cash used in the period hit $-10.9M, and the firm’s cash and cash equivalents stood at just $905,187 at year-end, down from earlier filings that showed inventory at $35,651 and an inventory reduction of $-37,956 over the same period. The company’s 20-F explicitly states it is ‘substantially dependent’ on its GrowHub Platform for revenue and warns that ‘inability to release enhanced versions of our GrowHub Platform on a timely basis’ could further constrain growth, which is a polite way of saying the platform’s uptake has not matched the pitch-deck projections.

What GrowHub claims to do is set up blockchain-based traceability for supply chains, with a particular push into premium skincare as of June 2026 via a partnership with CARENESS, the skincare arm of Koufuku Group. The company’s own product pages trumpet the ability to ‘track products and individual batches at every stage of the supply chain, from the origin of raw materials through manufacturing to the end consumer,’ and promise ‘the integrity and authenticity of every product’ using its web app. Yet the filings do not disclose any revenue, contract value, or customer count tied to these traceability services, leaving the gap between the platform’s promise and the balance sheet’s reality unbridged.

The company’s ‘FIPWA Innovation Center’ is pitched as a ‘landing pad for businesses and entrepreneurs’ to ‘monetise products and services’ using the GrowHub blockchain, with access to ASEAN distribution channels and capital. The site boasts ‘a network of producers, distribution channels across ASEAN, and access to capital,’ yet the 20-F concedes that the market for the platform ‘grows more slowly than anticipated or if demand for our GrowHub Platform does not grow as quickly,’ a hedging clause that reads less like confidence and more like a company trying to talk its way out of insolvency risk.

The company’s most recent 6-K filings in July 2026 reference ongoing platform enhancements and partnerships but do not quantify their financial impact, while the June 2026 6-K reiterates the company’s dependence on the platform and the risk of delayed releases. The June 2025 6-K and May 2025 6-K similarly flag ‘risk factors’ including the platform’s slow uptake and the company’s inability to fund operations without further capital raises or dilution. The SEC filing index confirms a steady stream of 6-K and 20-F disclosures in 2025-2026, indicating active, if thin, disclosure rather than secrecy, but the filings themselves do not provide the missing metrics: customer counts, recurring revenue, gross margins, or a credible path to cash-flow positivity.

The company’s product visuals-clean product images of skincare bottles with blockchain icons and a promotional shot of the FIPWA Innovation Center-are eye-catching but do not substitute for filed financials. The evidence suggests GrowHub operates a blockchain-based traceability platform in name, but the filings show a firm whose real product appears to be a narrative: promising transparency while burning cash, selling a vision while lacking the numbers to back it up.

For context, the company’s cash and equivalents stood at $905,187 at year-end 2025, down from a higher balance earlier in the year, and the firm’s operating cash burn of $-10.9M over 2025 implies a runway measured in months rather than years at current burn rates. The company’s inventory balance fell by $-37,956 over the year, a figure that does not offset the cash burn, and capital expenditure in 2025 was a trivial $1,242-hardly the sign of a scaling tech platform. The 20-F explicitly warns that the company’s future depends on the timely release of enhanced platform versions and the growth of platform demand, two variables the filings do not evidence in hard numbers.